Clinical Program Manager
Wolters Kluwer Health
Wolters Kluwer Health
Because of ongoing revisions and lack of consistent regulatory scrutiny, many pharmacies have not yet developed a robust strategy for meeting the nonsterile compounding standards in USP General Chapter <795>. This delay may lead to patient safety risks or inspection findings, experts warn.
This lack of attention to nonsterile compounding is understandable, given the fact that many hospital pharmacies have been